- Home
- / TMS
TMS
Total Funding
$6.6 M
TMS Summary
Company Summary
- Overview
- TMS (株式会社ティムス) is a biotech company searching for drug seeds from its microbial library using its drug screening system. Its lead compound TMS-007 is indicated for acute ischemic stroke.
- Type
- Private
- Status
- Active
- Founded
- 2005
- Website
- http://www.tms-japan.co.jp/
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026